LA SALUTE DEL SENO


CONOSCERE IL PROPRIO SENO

http://www.breastcancercare.org.uk/breast-cancer-information/breast-awareness/being-breast-aware
http://www.breastcancercare.org.uk/breast-cancer-information/breast-awareness/being-breast-aware/changes-look-feel

PREVENZIONE PRIMARIA ALIMENTAZIONE E MOVIMENTO

Berrino F: Il cibo dell’uomo. Milano, Franco Angeli, Milano, 2010.

Branchi A, Antonietti A, Quaglia J, Merlani G: Abitudini alimentari e di movimento dei giovani ticinesi: principali risultati dell’indagine sulla salute dei giovani ticinesi tra gli 11 e i 15 anni nel 2010.
DATI 2012; 12 (2): 53-61.Lega svizzera contro il cancro: Consapevoli e sani: dieci suggerimenti della Lega svizzera contro il cancro.
Linkare su:http://www.legacancro.ch/it/prevenzione_/movimento/

Pieth J, Navarra K, Grabherr M: Il movimento nella  vita. Berna: Croce Rossa Svizzera, Scuola universitaria federale dello sport e Ufficio federale dello sport, 2008. Disponibile in 10 lingue, link:
http://www.migesplus.ch/it/pubblicazioni/alimentazione-movimento/show/il-movimento-e-vita-1/

Società Svizzera di Nutrizione: Piramide alimentare svizzera: raccomandazioni alimentari per adulti che conciliano piacere ed equilibrio nell’alimentazione. Berna: SSN: 2011.
Da linkare su:
http://www.sge-ssn.ch/it/io-e-te/mangiare-e-bere/in-modo-equilibrato/piramide-alimentare-svizzera/

Veronesi U: La grande sfida; sconfiggeremo il cancro con la prevenzione, la cura e la ricerca. Milano: RCS MediaGroup-Divisione quotidiani, 2013.

Villarini A, Allegro G: Prevenire i tumori mangiando con gusto. Milano: Sperling & Kupfer Editori, 2011.

Villarini A, Di Gangi F: Scegli ciA? che mangi: guida ai cibi che aiutano a proteggere la salute. Milano: Sperling & Kupfer Editori, 2011.

World Cancer Research Fund, American Institute for Cancer Research:Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington, DC.: AIRC, 2007.

Riassunto del rapporto in 8 lingue (inglese, francese, tedesco, spagnolo etc.)
linkare su:
http://www.wcrf.org/int/research-we-fund/our-cancer-prevention-recommendations
Rapporto integrale ( in inglese)
linkare su:
http://www.wcrf.org/sites/default/files/Second-Expert-Report.pdf

CONTROLLI SENOLOGICI E SCREENING MAMMOGRAFICO

Dipartimento della sanità e della socialità, sezione sanitaria e Europa Donna della Svizzera Italiana: La mammografia, un aiuto per capire e per decidere. Dipartimento della sanità  e della socialità, Sezione sanitaria e Europa Donna, Sezione Svizzera Italiana, Bellinzona 2008, revisione testo 2009,

Certification Protocol (European Reference Organisation for Quality Assured Breast Cancer Screening and Diagnostic Services).
www.euref.org

Swiss Cancer Screening

Centro Programma Screening Ticino

Documenti informativi per la popolazione; Centro Programma Screening Ticino

FATTORI DI RISCHIO

GENERALI

Cancer Australia, National Breast and Ovarian Cancer Centre: Breast cancer risk factors: a review of the evidence. National Breast and Ovarian Cancer Centre, Surry Hills, NSW, 2009.

Weir, R, Day, P, Ali W: Risk factors for breast cancer in women. NZHTA Report 2007; 10(2).

FAMILIARI

Genetic/familial high-risk assessment: breast and ovarian. National Comprehensive Cancer Network clinical practice guidelines in oncology (NCCN guidelines) version 2.2015.

BalmaAi??a J, DAi??ez O, Rubio IT, Cardoso F: ESMO Guidelines Working Group. BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22 Suppl 6:vi31-4

Profato JL, Arun BK: Genetic risk assessment for breast and gynecological malignancies. Curr Opin Obstet Gynecol. 2015;27(1):1-5.

Cuzick J, DeCensi A, Arun B e altri: Preventive therapy for breast cancer: a consensus statement. Lancet Oncol. 2011;12(5):496-503

Visvanathan K, Hurley P, Bantug E e altri: Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10;31(23):2942-62

IL TUMORE DEL SENO

DIAGNOSI TIPI DI TUMORE

Makki J. Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance.Clin Med Insights Pathol. 2015;8:23-31.

Ades F, Zardavas D, Bozovic-Spasojevic I e altri: Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. J Clin Oncol. 2014;32(25):2794-803

Guiu S, Michiels S, AndrAi?? F e altri: Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol. 2012;23(12):2997-3006

Penault-Llorca F, Viale G: Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective.Ann Oncol. 2012;23 Suppl 6:vi19-22

Stuart KE, Houssami N, Taylor R e altri: Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis. BMC Cancer. 2015;15:890

Mitchell KB, Kuerer H: Ductal Carcinoma In Situ: Treatment Update and Current Trends. Curr Oncol Rep. 2015;17(11):48

Vatovec C, Erten MZ, Kolodinsky J e altri: Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society. Crit Rev Eukaryot Gene Expr. 2014; 24(4):281-6

Staley H, McCallum I, Bruce J: Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis. Breast. 2014;23(5):546-51

Cutuli B, Bernier J, Poortmans P: Radiotherapy in DCIS, an underestimated benefit? Radiother Oncol. 2014l;112(1):1-8.

TRATTAMENTI ED EFFETTI COLLATERALI

TERAPIA CON I FARMACI

Coates AS, Winer EP, Goldhirsch A e altri: Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol. 2015;26(8):1533-46.

Partridge AH, Pagani O, Abulkhair O e altri: First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014;23(3):209-20.

Biganzoli L, Wildiers H, Oakman C e altri: Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol. 2012;13(4):e148-60

Cardoso F, Loibl S, Pagani O e altri: European Society of Breast Cancer Specialists. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012;48(18):3355-77

Senkus E, Kyriakides S, Ohno S e altri: ESMO Guidelines Committee. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v8-30

Burstein HJ, Temin S, Anderson H e altri: Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol. 2014;32(21):2255-69Loren AW, Mangu PB, Beck LN e altri. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500-10.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG): Peto R, Davies C, Godwin J e altri. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet. 2012 4;379(9814):432-44

Zagouri F, Liakou P, Bartsch R e altri: Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal. Breast. 2015 Aug;24(4):513-23.

EFFETTI COLLATERALI DEI TRATTAMENTI E CONSIGLI PRATICI

BC Cancer Agency. Managing symptoms and side effects in
http://www.bccancer.bc.ca/health-info/coping-with-cancer/managing-symptoms/hair-loss-appearance-changes

Helms Rebecca L. et al. 2008: Body image issues in women with breast cancer. Psychology, Health and Medicine. 13: 313-325.
BC Cancer Agency. Nutritional Guidelines for Symptom Management. Unwanted weight gain in:Ai?? http://www.bccancer.bc.ca/nutrition-site/Documents/UnwantedWeightGain.pdf

Lega svizzera contro il cancro:La terapia antitumorale ha cambiato il mio aspetto. Berna: Lega svizzera contro il cancro,2007 http://assets.krebsliga.ch/downloads/3020.pdf

Lemieux Julie et altri:Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho-Oncology 17: 317-328.2008

Gallagher P. et altri. 2009: Experience in the provision, fitting and supply of external breast protheses: findings from a national survey. European journal of cancer care: 18: 556-568.

Lega svizzera contro il cancro:La protesi del seno: la scelta giusta. Berna: Lega Svizzera contro il cancro  http://assets.krebsliga.ch/downloads/3401.pd 2010

DURANTE E DOPO I TRATTAMENTI

CONTROLLI

Khatcheressian JL, Hurley P, Bantug E e altri: American Society of Clinical Oncology. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961-5

Ferzoco RM, Ruddy KJ: Optimal delivery of male breast cancer follow-up care: improving outcomes. Breast Cancer (Dove Med Press). 2015;7:371-9.

ATTIVITÀ FISICA DOPO E DURANTE I TRATTAMENTI

WCRF – World Cancer Research Fund International.

Spei ME1, Samoli E2, Bravi F3, La Vecchia C4, Bamia C5, Benetou V6. Physical activity in breast cancer survivors: A systematic review and meta-analysis on overall and breast cancer survival. Breast. 2019 Apr;44:144-152. doi: 10.1016/j.breast.2019.02.001. Epub 2019 Feb 12.

De Boer MC1, Wörner EA1, Verlaan D1, van Leeuwen PAM2. The Mechanisms and Effects of Physical Activity on Breast Cancer. Clin Breast Cancer. 2017 Jul;17(4):272-278. doi: 10.1016/j.clbc.2017.01.006. Epub 2017 Jan 24.

Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: Consensus statement from International Multidisciplinary Roundtable. Medicine and Science in Sports and Exercise 2019; 51(11):2375-2390.

Holmes M.D., Chen W.Y., Feskanich D., Kroenke C.H., Colditz G.A. Physical activity and survival afeter breast cancer diagnosis. Jama, 2005, 293, pp. 2479-86.

Holmes M.D., Chen W.Y., Feskanich D., Kroenke C.H., Colditz G.A. Physical activity and survival afeter breast cancer diagnosis. Jama, 2005, 293, pp. 2479-86.

GESTIONE DEL PESO DURANTE E DOPO LE TERAPIE 

AIRC – Fondazione AIRC per la Ricerca sul Cancro

Bray F., McCarron P., Parkin D.M., The changing global patterns of female breast cancer incidence and mortality, Breast Cancer Res. 6 (6) (2004) 229e

Kroemer G., Senovilla L., Galluzzi L., et al., Natural and therapy-induced immunosurveillance in breast cancer, Nat. Med. 21 (10) (2015 Oct) 1128e

Nichols H.B., Trentham-Dietz A., Egan K.M., et al. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality, Cancer Epidemiol. Biomark. Prev. 18 (5) (2009 May) 1403e

Peairs K.S., Barone B.B., Snyder C.F., et al., Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis, J. Clin. Oncol. 29 (1) (2011 Jan 1) 40e

Renehan A.G., Roberts D.L., Dive C., Obesity and cancer: pathophysiological and biological mechanisms, Arch. Physiol. Biochem. 114 (1) (2008 Feb) 71e

WCRF – Wolrd Cancer Research Fund.

WCRF- RACCOMANDAZIONI DURANTE E DOPO LE TERAPIE

AIRC – Fondazione AIRC per la Ricerca sul Cancro

WCRF – Wolrd Cancer Research Fund

ALIMENTAZIONE DURANTE E DOPO LE TERAPIE

Agnoli C., Grioni S., Sieri S., et al., Metabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre italian cohort, PLoS One 10 (6) (2015 Jun 1) e0128891.

KH, Nordestgaard BG, Flyger H, Bojesen SE (2011) Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. Breast Cancer Res

Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G, Kaaks R: Reducing bioavailable sex hormones through a comprehensive ch’ange in diet: the Diet and Androgens (DIANA) randomized trial. Cancer Epidemiology, Biomarkers & Prevention 2001, 10:25-33.

Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, Berselli E, Muti P, Secreto G: Serum testosterone levels and breast cancer prognosis. International Journal of Cancer 2005, 113:499-502.

Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579–591.

Chen W.W., Shao Y.Y., Shau W.Y., et al., The impact of diabetes mellitus on prognosis of early breast cancer in Asia, Oncologist 17 (4) (2012) 485e

Cleveland R.J., North K.E., Stevens J., et al., The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project, Cancer Causes Control 23 (7) (2012 Jul) 1193e

Esmaillzadeh A ,J Nutr.2007;137:992-8.

Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA: Vascular endothelial growth factor and angiogenesis. Ph0armacol Rev 2004; 56: 549–580.

Ibrahim YH, Yee D: Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res 2004; 14: 261–269.

Kaaks R, Bellati C, Venturelli E, Rinaldi S, Secreto G, Biessy C, Pala V, Sieri S, Berrino F: Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) randomized trial. European Journal of Clinical Nutrition 2003, 57:1079-88.

Levitan EB Metabolism.2008;57:437.

Liu S Am J Clin Nutr. 2002;75:492.

Nettleton JA, Am J Clin Nutr.2006;83:1369-79.

Norat T, Dossus L, Rinaldi S, Overvad K, Gronbaek H, Tjonneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Boeing H, Lahmann PH, Linseisen J, Nagel G, Trichopoulou A, Trichopoulos D, Kalapothaki V, Sieri S, Palli D, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Agudo A, Amiano P, Ardanoz E, Martinez C, Quiros R, Tormo MJ, Bingham S, Key TJ, Allen NE, Ferrari P, Slimani N, Riboli E, Kaaks R: Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr, 61: 91-98, 2007.

Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S : Metabolic syndrome as a prognostic factor breast cancer recurrences. International Journal of Cancer 2006, 119: 236-238.

 

 

GRAVIDANZA

Peccatori FA, Azim HA Jr, Orecchia R e altri: ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi160-70.

Pagani O, Partridge A, Korde L e altri: Breast International Group; North American Breast Cancer Group Endocrine Working Group. Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat. 2011 Sep;129(2):309-17

Loren AW, Mangu PB, Beck LN e altri: Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500-10.

QUANDO LA MALATTIA SI RIPRESENTA

Senkus E, Cardoso F, Pagani O: Time for more optimism in metastatic breast cancer? Cancer Treat Rev. 2014 Mar;40(2):220-8

TERAPIA CON I FARMACI

Cardoso F, Costa A, Norton L e altri:European School of Oncology; European Society of Medical Oncology. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast. 2014;23(5):489-502.

McCutcheon S, Cardoso F: Challenges in optimizing care in advanced breast cancer patients: Results of an international survey linked to the ABC1 consensus conference. Breast. 2015;24(5):623-9.

Cardoso F, Harbeck N, Fallowfield L e altri: ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012 Oct;23 Suppl 7:vii11-9

Partridge AH, Pagani O, Abulkhair O e altri: First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014;23(3):209-20.

Gradishar WJ: Optimizing Treatment of HER2-Positive Breast Cancer. J Natl Compr Canc Netw. 2015;13(5 Suppl):649-51

Lin NU, Thomssen C, Cardoso F e altri: European School of Oncology-Metastatic Breast Cancer Task Force. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer. Breast. 2013; 22(3):203-10

Carlson RW, Allred DC, Anderson BO e altri: National Comprehensive Cancer Network. Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012;10(7):821-9

Biganzoli L, Wildiers H, Oakman C e altri: Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol. 2012;13(4):e148-60

IL TUMORE DEL SENO MASCHILE

PDQ Adult Treatment Editorial Board: Male Breast Cancer Treatment (PDQAi??): Health Professional Version. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2016 Feb 4.

Sousa B, Moser E, Cardoso F: An update on male breast cancer and future directions for research and treatment. Eur J Pharmacol. 2013 Oct 5;717(1-3):71-83

Cardoso F, Costa A, Norton L e altri:European School of Oncology; European Society of Medical Oncology. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast. 2014;23(5):489-502.

Senkus E, Kyriakides S, Ohno S e altri: ESMO Guidelines Committee. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v8-30

Korde LA, Zujewski JA, Kamin L e altri: Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010 Apr 20;28(12):2114-22

RICERCA CLINICA

World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects
http://www.who.int/bulletin/archives/79(4)373.pdf

Partecipasalute Partecipa alla ricerca
http://www.partecipasalute.it/cms_2/partecipa_alla_ricerca

Ecranproject – European Communication on Research Awareness Needs
http://www.ecranproject.eu/it

Swissmedic Sperimentazioni cliniche  Leggi applicabili
https://www.swissmedic.ch/bewilligungen/00155/00242/index.html?lang=it

Pagina aggiornata al 17 novembre 2020